600535:SHA
Tasly Pharmaceutical Group Co Ltd
14,04 CN¥
arrow_downward
-0,35%(-0,050) 1D
16 tet, 3:00:00 m.d., GMT+8 · CNY
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për 600535...
Hap
14,18 CN¥
I lartë
14,35 CN¥
I ulët
13,92 CN¥
Kapitalizimi i tregut
20,87 mld
Vëllimi mesatar
11,45 mln
Vëllimi
15,72 mln
Dividendi
2,42%
Dividendi tremujor
0,09 CN¥
Data e ndërprerjes së dividendit
29 maj 2026
Raporti çmim/fitim
17,15
Maksimumi 52-javor
16,24 CN¥
Minimumi 52-javor
12,90 CN¥
Fitimet për aksion
0,82 CN¥
Aksionet në qarkullim
1,51 mld
Numri i punonjësve
11 mijë
Hap
14,18 CN¥
I lartë
14,35 CN¥
I ulët
13,92 CN¥
Kapitalizimi i tregut
20,87 mld
Vëllimi mesatar
11,45 mln
Vëllimi
15,72 mln
Dividendi
2,42%
Dividendi tremujor
0,09 CN¥
Data e ndërprerjes së dividendit
29 maj 2026
Raporti çmim/fitim
17,15
Maksimumi 52-javor
16,24 CN¥
Minimumi 52-javor
12,90 CN¥
Fitimet për aksion
0,82 CN¥
Aksionet në qarkullim
1,51 mld
Numri i punonjësve
11 mijë
Aksionet e lidhura
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
PR Newswire
·
45 minuta më parë
BCRF Launches $100 Million Venture Program for Breast Cancer: NYSE Content Update
Stock Titan
·
29 minuta më parë
A voluntary Nasdaq exit covers CECO Environmental (Nasdaq: CECO) common stock.
www.marketscreener.com
·
54 minuta më parë
Fabric.AI to Participate in Live YouTube “Ask Me Anything” Panel from Nasdaq MarketSite on the Future of AI Infrastructure
Seeking Alpha
·
23 minuta më parë
How And Why I Became A Bond Manager. Hint: The S&P 500 Made Me Do It (NASDAQ:QQQ)
Profili
Tasly is a Chinese pharmaceutical company based in the city of Tianjin. It was established in 1994 and is notably producing traditional Chinese medicines.
It has a turnover of 4 billion US dollars, 10,000 employees and is listed on the Shanghai Stock Exchange.
In 2009, Chinese pharmacologist Li Lianda claimed that a key product made by Tasly was unsafe. Tasly sued Li in 2013, alleging that Li's claim was baseless and was motivated by his financial and employment relations with Guangzhou Pharmaceutical, a direct competitor of Tasly. In September 2014, the Tianjin High People's Court ruled in favour of Tasly and ordered Li to issue an apology and pay Tasly 300,000 yuan in compensation.
In February 2017, Tasly announced plans to form a joint venture with American multi-level marketing company Herbalife. Wikipedia
Rreth Tasly Pharmaceutical Group Co Ltd